Chapter 9: Designing Adaptive Organizations
dropped as needed, much like adding pieces to a three-dimensional puzzle. Because modular
organizations pay for outsourced labor, expertise, or manufacturing capabilities only when needed, they
As part of its move toward becoming a modular organization, Lilly created a group within the company
Why did Lilly turn to a modular organization structure? “Trying to do everything yourself won’t work.
The odds of owning everything and being at the right place at the right time are not high,” said Peter
Johnson, Lilly’s vice president of corporate strategic planning.
How well is Chorus working? Thus far, 25% of the molecules the Chorus has had other research
companies investigate have proved worthy of further study. And one discovery, a treatment for
Finally, to what extent should Lilly outsource parts of its drug development process to outside vendors
and companies? Because you risk creating new competitors with your own dollars when you outsource, a
general guideline is to only outsource noncore business activities But, when you’re a pharmaceutical
firm, drug development is the core of your business. Is there a way for Lilly to effectively outsource drug
development that gets around those risks? Tick tock. Tick tock. The clock is running.
By choosing to become a modular organization which significantly relies on outsourcing, Lilly was
hoping to significantly reduce costs while simultaneously increasing the speed with which it was able to
test and bring drugs to market. The downside of modular organizations, as discussed above, is the loss of
So, is Lilly risking its future by outsourcing the core function of researching and testing new drugs?
It turns out that contract research organizations (CROs), which do this kind of research, have been around
The advantage to Lilly is that by outsourcing drug testing, it can test two to three times as many drugs
at the same time for half of the cost. Robert Armstrong, Lilly’s vice president of global external Research